These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 797180)

  • 41. Pigment production by Cryptococcus neoformans and other Cryptococcus species from aminophenols and diaminobenzenes.
    Chaskes S; Tyndall RL
    J Clin Microbiol; 1978 Feb; 7(2):146-52. PubMed ID: 344335
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Proteolytic activity of a clinical isolate of Cryptococcus neoformans.
    Brueske CH
    J Clin Microbiol; 1986 Mar; 23(3):631-3. PubMed ID: 3514663
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Light microscopy of basidia, basidiospores, and nuclei in spores and hyphae of Filobasidiella neoformans (Cryptococcus neoformans).
    Erke KH
    J Bacteriol; 1976 Oct; 128(1):445-55. PubMed ID: 789347
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pigmentation and autofluorescence of Cryptococcus species after growth on tryptophan and anthranilic acid media.
    Chaskes S; Tyndall RL
    Mycopathologia; 1978 Oct; 64(2):105-12. PubMed ID: 366422
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Characterization of phenotypic switching in Cryptococcus neoformans biofilms.
    Martinez LR; Ibom DC; Casadevall A; Fries BC
    Mycopathologia; 2008 Oct; 166(4):175-80. PubMed ID: 18568421
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Morphogenesis of Filobasidiella neoformans, the sexual state of Cryptococcus neoformans.
    Kwon-Chung KJ
    Mycologia; 1976; 68(4):821-33. PubMed ID: 790172
    [No Abstract]   [Full Text] [Related]  

  • 47. Heteronuclear NMR studies of metabolites produced by Cryptococcus neoformans in culture media: identification of possible virulence factors.
    Bubb WA; Wright LC; Cagney M; Santangelo RT; Sorrell TC; Kuchel PW
    Magn Reson Med; 1999 Sep; 42(3):442-53. PubMed ID: 10467288
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The in vivo incorporation of [32P]-labeled orthophosphate into pyrophosphatidic acid and other phospholipids of Cryptococcus neoformans through cell growth.
    Itoh T; Kaneko H
    Lipids; 1977 Oct; 12(10):809-13. PubMed ID: 199826
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Identification of Heparin-binding Proteins on the Cell Surface of Cryptococcus neoformans].
    Ikeda R; Ichikawa T; Tsukiji YK; Kawamura K; Kikuchi A; Ishida YI; Ogasawara Y
    Med Mycol J; 2018; 59(3):E47-E52. PubMed ID: 30175812
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Evaluation of a fluorescent method (fluorescein diacetate and ethidium bromide solution) in the study of the viability Cryptococcus neoformans strains.
    Correa B; Purchio A; Paula CR; Gambale W
    Mycopathologia; 1986 Nov; 96(2):91-6. PubMed ID: 3540676
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Metabolomic alterations associated with copper stress in
    Sun T; Li X; Song W; Yu S; Wang L; Ding C; Xu Y
    Future Microbiol; 2021 Mar; 16():305-316. PubMed ID: 33635120
    [No Abstract]   [Full Text] [Related]  

  • 52. Relationship between polyene resistance and sterol compositions in Cryptococcus neoformans.
    Kim SJ; Kwon-Chung J; Milne GW; Hill WB; Patterson G
    Antimicrob Agents Chemother; 1975 Jan; 7(1):99-106. PubMed ID: 1094946
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Early capsule structure changes associated with Cryptococcus neoformans crossing of the blood-brain barrier].
    Charlier C; Chrétien F; Lortholary O; Dromer F
    Med Sci (Paris); 2005; 21(8-9):685-7. PubMed ID: 16115446
    [No Abstract]   [Full Text] [Related]  

  • 54. [Structure of Cryptococcus neoformans capsule].
    MOLNAR J
    Kiserl Orvostud; 1956 Sep; 8(5):498-501. PubMed ID: 13386051
    [No Abstract]   [Full Text] [Related]  

  • 55. Effect of temperature on growth and macromolecular biosynthesis in Cryptococcus species.
    Heere LJ; Mahvi TA; Annable MM
    Mycopathologia; 1975 Apr; 55(2):105-13. PubMed ID: 1093034
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Cryptococcus neoformans: pigment formation on polyphenols].
    Pulverer G; Korth H
    Med Microbiol Immunol; 1971; 157(1):46-51. PubMed ID: 4947982
    [No Abstract]   [Full Text] [Related]  

  • 57. Cytochemical and biochemical identification of lysosomes in Cryptococcus neoformans.
    Mason DL; Wilson CL
    Mycopathologia; 1979 Sep; 68(3):183-90. PubMed ID: 394002
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Capsule synthesis by Cryptococcus neoformans.
    LITTMAN ML
    Trans N Y Acad Sci; 1958 May; 20(7):623-48. PubMed ID: 13556861
    [No Abstract]   [Full Text] [Related]  

  • 59. Pathogenicity of the hyphae of Filobasidiella neoformans.
    Zimmer BL; Hempel HO; Goodman NL
    Mycopathologia; 1983 Feb; 81(2):107-10. PubMed ID: 6343881
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Secreted Acb1 Contributes to the Yeast-to-Hypha Transition in Cryptococcus neoformans.
    Xu X; Zhao Y; Kirkman E; Lin X
    Appl Environ Microbiol; 2016 Feb; 82(4):1069-1079. PubMed ID: 26637591
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.